Global Antibody Services Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Summary
Antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of antibody production—from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification. They also immunize with recombinant proteins or protein fragments provided by the customers(or expressed and purified in labs using cDNAs from the service providers’ extensive in-house genomics library) to generate antibodies in rabbits, chickens, goats, guinea pigs, mice, or rats.
According to APO Research, The global Antibody Services market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Antibody Services is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Antibody Services is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Antibody Services is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Antibody Services is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Antibody Services include ThermoFisher, GenScript, Abcam, MBS, ROCKLAND, ProSci, Anaspec, Bio-Rad and Covance, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Antibody Services, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Antibody Services, also provides the value of main regions and countries. Of the upcoming market potential for Antibody Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Antibody Services revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Antibody Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Antibody Services company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Antibody Services segment by Company
1. To analyze and research the global Antibody Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Antibody Services key companies, revenue, market share, and recent developments.
3. To split the Antibody Services breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Antibody Services market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Antibody Services significant trends, drivers, influence factors in global and regions.
6. To analyze Antibody Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibody Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antibody Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibody Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antibody Services industry.
Chapter 3: Detailed analysis of Antibody Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Antibody Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Antibody Services in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
Antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of antibody production—from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification. They also immunize with recombinant proteins or protein fragments provided by the customers(or expressed and purified in labs using cDNAs from the service providers’ extensive in-house genomics library) to generate antibodies in rabbits, chickens, goats, guinea pigs, mice, or rats.
According to APO Research, The global Antibody Services market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Antibody Services is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Antibody Services is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Antibody Services is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Antibody Services is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Antibody Services include ThermoFisher, GenScript, Abcam, MBS, ROCKLAND, ProSci, Anaspec, Bio-Rad and Covance, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Antibody Services, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Antibody Services, also provides the value of main regions and countries. Of the upcoming market potential for Antibody Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Antibody Services revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Antibody Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Antibody Services company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Antibody Services segment by Company
- ThermoFisher
- GenScript
- Abcam
- MBS
- ROCKLAND
- ProSci
- Anaspec
- Bio-Rad
- Covance
- Capra Science
- Innovagen
- APS
- Randox
- GL Biochem
- Abgent
- Monoclonal
- Polyclonal
- Others
- BioScience Companies
- BioScience Research Institutions
- Hospitals
- Other
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Antibody Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Antibody Services key companies, revenue, market share, and recent developments.
3. To split the Antibody Services breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Antibody Services market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Antibody Services significant trends, drivers, influence factors in global and regions.
6. To analyze Antibody Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibody Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antibody Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibody Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antibody Services industry.
Chapter 3: Detailed analysis of Antibody Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Antibody Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Antibody Services in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Antibody Services Market Size, 2019 VS 2023 VS 2030
1.3 Global Antibody Services Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 ANTIBODY SERVICES MARKET DYNAMICS
2.1 Antibody Services Industry Trends
2.2 Antibody Services Industry Drivers
2.3 Antibody Services Industry Opportunities and Challenges
2.4 Antibody Services Industry Restraints
3 ANTIBODY SERVICES MARKET BY COMPANY
3.1 Global Antibody Services Company Revenue Ranking in 2023
3.2 Global Antibody Services Revenue by Company (2019-2024)
3.3 Global Antibody Services Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Antibody Services Company Manufacturing Base & Headquarters
3.5 Global Antibody Services Company, Product Type & Application
3.6 Global Antibody Services Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Antibody Services Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Antibody Services Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 ANTIBODY SERVICES MARKET BY TYPE
4.1 Antibody Services Type Introduction
4.1.1 Monoclonal
4.1.2 Polyclonal
4.1.3 Others
4.2 Global Antibody Services Sales Value by Type
4.2.1 Global Antibody Services Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Antibody Services Sales Value by Type (2019-2030)
4.2.3 Global Antibody Services Sales Value Share by Type (2019-2030)
5 ANTIBODY SERVICES MARKET BY APPLICATION
5.1 Antibody Services Application Introduction
5.1.1 BioScience Companies
5.1.2 BioScience Research Institutions
5.1.3 Hospitals
5.1.4 Other
5.2 Global Antibody Services Sales Value by Application
5.2.1 Global Antibody Services Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Antibody Services Sales Value by Application (2019-2030)
5.2.3 Global Antibody Services Sales Value Share by Application (2019-2030)
6 ANTIBODY SERVICES MARKET BY REGION
6.1 Global Antibody Services Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Antibody Services Sales Value by Region (2019-2030)
6.2.1 Global Antibody Services Sales Value by Region: 2019-2024
6.2.2 Global Antibody Services Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Antibody Services Sales Value (2019-2030)
6.3.2 North America Antibody Services Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Antibody Services Sales Value (2019-2030)
6.4.2 Europe Antibody Services Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Antibody Services Sales Value (2019-2030)
6.5.2 Asia-Pacific Antibody Services Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Antibody Services Sales Value (2019-2030)
6.6.2 Latin America Antibody Services Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Antibody Services Sales Value (2019-2030)
6.7.2 Middle East & Africa Antibody Services Sales Value Share by Country, 2023 VS 2030
7 ANTIBODY SERVICES MARKET BY COUNTRY
7.1 Global Antibody Services Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Antibody Services Sales Value by Country (2019-2030)
7.2.1 Global Antibody Services Sales Value by Country (2019-2024)
7.2.2 Global Antibody Services Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.3.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.4.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.5.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.6.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.7.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.8.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.9.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.10.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.11.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.12.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.13.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.14.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.15.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.16.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.17.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.18.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.19.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.20.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.21.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 ThermoFisher
8.1.1 ThermoFisher Comapny Information
8.1.2 ThermoFisher Business Overview
8.1.3 ThermoFisher Antibody Services Revenue and Gross Margin (2019-2024)
8.1.4 ThermoFisher Antibody Services Product Portfolio
8.1.5 ThermoFisher Recent Developments
8.2 GenScript
8.2.1 GenScript Comapny Information
8.2.2 GenScript Business Overview
8.2.3 GenScript Antibody Services Revenue and Gross Margin (2019-2024)
8.2.4 GenScript Antibody Services Product Portfolio
8.2.5 GenScript Recent Developments
8.3 Abcam
8.3.1 Abcam Comapny Information
8.3.2 Abcam Business Overview
8.3.3 Abcam Antibody Services Revenue and Gross Margin (2019-2024)
8.3.4 Abcam Antibody Services Product Portfolio
8.3.5 Abcam Recent Developments
8.4 MBS
8.4.1 MBS Comapny Information
8.4.2 MBS Business Overview
8.4.3 MBS Antibody Services Revenue and Gross Margin (2019-2024)
8.4.4 MBS Antibody Services Product Portfolio
8.4.5 MBS Recent Developments
8.5 ROCKLAND
8.5.1 ROCKLAND Comapny Information
8.5.2 ROCKLAND Business Overview
8.5.3 ROCKLAND Antibody Services Revenue and Gross Margin (2019-2024)
8.5.4 ROCKLAND Antibody Services Product Portfolio
8.5.5 ROCKLAND Recent Developments
8.6 ProSci
8.6.1 ProSci Comapny Information
8.6.2 ProSci Business Overview
8.6.3 ProSci Antibody Services Revenue and Gross Margin (2019-2024)
8.6.4 ProSci Antibody Services Product Portfolio
8.6.5 ProSci Recent Developments
8.7 Anaspec
8.7.1 Anaspec Comapny Information
8.7.2 Anaspec Business Overview
8.7.3 Anaspec Antibody Services Revenue and Gross Margin (2019-2024)
8.7.4 Anaspec Antibody Services Product Portfolio
8.7.5 Anaspec Recent Developments
8.8 Bio-Rad
8.8.1 Bio-Rad Comapny Information
8.8.2 Bio-Rad Business Overview
8.8.3 Bio-Rad Antibody Services Revenue and Gross Margin (2019-2024)
8.8.4 Bio-Rad Antibody Services Product Portfolio
8.8.5 Bio-Rad Recent Developments
8.9 Covance
8.9.1 Covance Comapny Information
8.9.2 Covance Business Overview
8.9.3 Covance Antibody Services Revenue and Gross Margin (2019-2024)
8.9.4 Covance Antibody Services Product Portfolio
8.9.5 Covance Recent Developments
8.10 Capra Science
8.10.1 Capra Science Comapny Information
8.10.2 Capra Science Business Overview
8.10.3 Capra Science Antibody Services Revenue and Gross Margin (2019-2024)
8.10.4 Capra Science Antibody Services Product Portfolio
8.10.5 Capra Science Recent Developments
8.11 Innovagen
8.11.1 Innovagen Comapny Information
8.11.2 Innovagen Business Overview
8.11.3 Innovagen Antibody Services Revenue and Gross Margin (2019-2024)
8.11.4 Innovagen Antibody Services Product Portfolio
8.11.5 Innovagen Recent Developments
8.12 APS
8.12.1 APS Comapny Information
8.12.2 APS Business Overview
8.12.3 APS Antibody Services Revenue and Gross Margin (2019-2024)
8.12.4 APS Antibody Services Product Portfolio
8.12.5 APS Recent Developments
8.13 Randox
8.13.1 Randox Comapny Information
8.13.2 Randox Business Overview
8.13.3 Randox Antibody Services Revenue and Gross Margin (2019-2024)
8.13.4 Randox Antibody Services Product Portfolio
8.13.5 Randox Recent Developments
8.14 GL Biochem
8.14.1 GL Biochem Comapny Information
8.14.2 GL Biochem Business Overview
8.14.3 GL Biochem Antibody Services Revenue and Gross Margin (2019-2024)
8.14.4 GL Biochem Antibody Services Product Portfolio
8.14.5 GL Biochem Recent Developments
8.15 Abgent
8.15.1 Abgent Comapny Information
8.15.2 Abgent Business Overview
8.15.3 Abgent Antibody Services Revenue and Gross Margin (2019-2024)
8.15.4 Abgent Antibody Services Product Portfolio
8.15.5 Abgent Recent Developments
9 CONCLUDING INSIGHTS
10 APPENDIX
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
1.1 Product Definition
1.2 Global Antibody Services Market Size, 2019 VS 2023 VS 2030
1.3 Global Antibody Services Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 ANTIBODY SERVICES MARKET DYNAMICS
2.1 Antibody Services Industry Trends
2.2 Antibody Services Industry Drivers
2.3 Antibody Services Industry Opportunities and Challenges
2.4 Antibody Services Industry Restraints
3 ANTIBODY SERVICES MARKET BY COMPANY
3.1 Global Antibody Services Company Revenue Ranking in 2023
3.2 Global Antibody Services Revenue by Company (2019-2024)
3.3 Global Antibody Services Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Antibody Services Company Manufacturing Base & Headquarters
3.5 Global Antibody Services Company, Product Type & Application
3.6 Global Antibody Services Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Antibody Services Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Antibody Services Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 ANTIBODY SERVICES MARKET BY TYPE
4.1 Antibody Services Type Introduction
4.1.1 Monoclonal
4.1.2 Polyclonal
4.1.3 Others
4.2 Global Antibody Services Sales Value by Type
4.2.1 Global Antibody Services Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Antibody Services Sales Value by Type (2019-2030)
4.2.3 Global Antibody Services Sales Value Share by Type (2019-2030)
5 ANTIBODY SERVICES MARKET BY APPLICATION
5.1 Antibody Services Application Introduction
5.1.1 BioScience Companies
5.1.2 BioScience Research Institutions
5.1.3 Hospitals
5.1.4 Other
5.2 Global Antibody Services Sales Value by Application
5.2.1 Global Antibody Services Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Antibody Services Sales Value by Application (2019-2030)
5.2.3 Global Antibody Services Sales Value Share by Application (2019-2030)
6 ANTIBODY SERVICES MARKET BY REGION
6.1 Global Antibody Services Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Antibody Services Sales Value by Region (2019-2030)
6.2.1 Global Antibody Services Sales Value by Region: 2019-2024
6.2.2 Global Antibody Services Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Antibody Services Sales Value (2019-2030)
6.3.2 North America Antibody Services Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Antibody Services Sales Value (2019-2030)
6.4.2 Europe Antibody Services Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Antibody Services Sales Value (2019-2030)
6.5.2 Asia-Pacific Antibody Services Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Antibody Services Sales Value (2019-2030)
6.6.2 Latin America Antibody Services Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Antibody Services Sales Value (2019-2030)
6.7.2 Middle East & Africa Antibody Services Sales Value Share by Country, 2023 VS 2030
7 ANTIBODY SERVICES MARKET BY COUNTRY
7.1 Global Antibody Services Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Antibody Services Sales Value by Country (2019-2030)
7.2.1 Global Antibody Services Sales Value by Country (2019-2024)
7.2.2 Global Antibody Services Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.3.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.4.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.5.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.6.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.7.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.8.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.9.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.10.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.11.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.12.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.13.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.14.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.15.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.16.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.17.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.18.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.19.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.20.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Antibody Services Sales Value Growth Rate (2019-2030)
7.21.2 Global Antibody Services Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Antibody Services Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 ThermoFisher
8.1.1 ThermoFisher Comapny Information
8.1.2 ThermoFisher Business Overview
8.1.3 ThermoFisher Antibody Services Revenue and Gross Margin (2019-2024)
8.1.4 ThermoFisher Antibody Services Product Portfolio
8.1.5 ThermoFisher Recent Developments
8.2 GenScript
8.2.1 GenScript Comapny Information
8.2.2 GenScript Business Overview
8.2.3 GenScript Antibody Services Revenue and Gross Margin (2019-2024)
8.2.4 GenScript Antibody Services Product Portfolio
8.2.5 GenScript Recent Developments
8.3 Abcam
8.3.1 Abcam Comapny Information
8.3.2 Abcam Business Overview
8.3.3 Abcam Antibody Services Revenue and Gross Margin (2019-2024)
8.3.4 Abcam Antibody Services Product Portfolio
8.3.5 Abcam Recent Developments
8.4 MBS
8.4.1 MBS Comapny Information
8.4.2 MBS Business Overview
8.4.3 MBS Antibody Services Revenue and Gross Margin (2019-2024)
8.4.4 MBS Antibody Services Product Portfolio
8.4.5 MBS Recent Developments
8.5 ROCKLAND
8.5.1 ROCKLAND Comapny Information
8.5.2 ROCKLAND Business Overview
8.5.3 ROCKLAND Antibody Services Revenue and Gross Margin (2019-2024)
8.5.4 ROCKLAND Antibody Services Product Portfolio
8.5.5 ROCKLAND Recent Developments
8.6 ProSci
8.6.1 ProSci Comapny Information
8.6.2 ProSci Business Overview
8.6.3 ProSci Antibody Services Revenue and Gross Margin (2019-2024)
8.6.4 ProSci Antibody Services Product Portfolio
8.6.5 ProSci Recent Developments
8.7 Anaspec
8.7.1 Anaspec Comapny Information
8.7.2 Anaspec Business Overview
8.7.3 Anaspec Antibody Services Revenue and Gross Margin (2019-2024)
8.7.4 Anaspec Antibody Services Product Portfolio
8.7.5 Anaspec Recent Developments
8.8 Bio-Rad
8.8.1 Bio-Rad Comapny Information
8.8.2 Bio-Rad Business Overview
8.8.3 Bio-Rad Antibody Services Revenue and Gross Margin (2019-2024)
8.8.4 Bio-Rad Antibody Services Product Portfolio
8.8.5 Bio-Rad Recent Developments
8.9 Covance
8.9.1 Covance Comapny Information
8.9.2 Covance Business Overview
8.9.3 Covance Antibody Services Revenue and Gross Margin (2019-2024)
8.9.4 Covance Antibody Services Product Portfolio
8.9.5 Covance Recent Developments
8.10 Capra Science
8.10.1 Capra Science Comapny Information
8.10.2 Capra Science Business Overview
8.10.3 Capra Science Antibody Services Revenue and Gross Margin (2019-2024)
8.10.4 Capra Science Antibody Services Product Portfolio
8.10.5 Capra Science Recent Developments
8.11 Innovagen
8.11.1 Innovagen Comapny Information
8.11.2 Innovagen Business Overview
8.11.3 Innovagen Antibody Services Revenue and Gross Margin (2019-2024)
8.11.4 Innovagen Antibody Services Product Portfolio
8.11.5 Innovagen Recent Developments
8.12 APS
8.12.1 APS Comapny Information
8.12.2 APS Business Overview
8.12.3 APS Antibody Services Revenue and Gross Margin (2019-2024)
8.12.4 APS Antibody Services Product Portfolio
8.12.5 APS Recent Developments
8.13 Randox
8.13.1 Randox Comapny Information
8.13.2 Randox Business Overview
8.13.3 Randox Antibody Services Revenue and Gross Margin (2019-2024)
8.13.4 Randox Antibody Services Product Portfolio
8.13.5 Randox Recent Developments
8.14 GL Biochem
8.14.1 GL Biochem Comapny Information
8.14.2 GL Biochem Business Overview
8.14.3 GL Biochem Antibody Services Revenue and Gross Margin (2019-2024)
8.14.4 GL Biochem Antibody Services Product Portfolio
8.14.5 GL Biochem Recent Developments
8.15 Abgent
8.15.1 Abgent Comapny Information
8.15.2 Abgent Business Overview
8.15.3 Abgent Antibody Services Revenue and Gross Margin (2019-2024)
8.15.4 Abgent Antibody Services Product Portfolio
8.15.5 Abgent Recent Developments
9 CONCLUDING INSIGHTS
10 APPENDIX
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
LIST OF TABLES
Table 1. Antibody Services Industry Trends
Table 2. Antibody Services Industry Drivers
Table 3. Antibody Services Industry Opportunities and Challenges
Table 4. Antibody Services Industry Restraints
Table 5. Global Antibody Services Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Antibody Services Revenue Share by Company (2019-2024)
Table 7. Global Antibody Services Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 8. Global Antibody Services Key Company Manufacturing Base & Headquarters
Table 9. Global Antibody Services Company, Product Type & Application
Table 10. Global Antibody Services Company Commercialization Time
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Antibody Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Major Companies of Monoclonal
Table 15. Major Companies of Polyclonal
Table 16. Major Companies of Others
Table 17. Global Antibody Services Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 18. Global Antibody Services Sales Value by Type (2019-2024) & (US$ Million)
Table 19. Global Antibody Services Sales Value by Type (2025-2030) & (US$ Million)
Table 20. Global Antibody Services Sales Value Share by Type (2019-2024)
Table 21. Global Antibody Services Sales Value Share by Type (2025-2030)
Table 22. Major Companies of BioScience Companies
Table 23. Major Companies of BioScience Research Institutions
Table 24. Major Companies of Hospitals
Table 25. Major Companies of Other
Table 26. Global Antibody Services Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 27. Global Antibody Services Sales Value by Application (2019-2024) & (US$ Million)
Table 28. Global Antibody Services Sales Value by Application (2025-2030) & (US$ Million)
Table 29. Global Antibody Services Sales Value Share by Application (2019-2024)
Table 30. Global Antibody Services Sales Value Share by Application (2025-2030)
Table 31. Global Antibody Services Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 32. Global Antibody Services Sales Value by Region (2019-2024) & (US$ Million)
Table 33. Global Antibody Services Sales Value Share by Region (2019-2024)
Table 34. Global Antibody Services Sales Value by Region (2025-2030) & (US$ Million)
Table 35. Global Antibody Services Sales Value Share by Region (2025-2030)
Table 36. Global Antibody Services Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 37. Global Antibody Services Sales Value by Country (2019-2024) & (US$ Million)
Table 38. Global Antibody Services Sales Value Market Share by Country (2019-2024)
Table 39. Global Antibody Services Sales Value by Country (2025-2030) & (US$ Million)
Table 40. Global Antibody Services Sales Value Market Share by Country (2025-2030)
Table 41. ThermoFisher Company Information
Table 42. ThermoFisher Business Overview
Table 43. ThermoFisher Antibody Services Revenue (US$ Million) and Gross Margin (2019-2024)
Table 44. ThermoFisher Antibody Services Product Portfolio
Table 45. ThermoFisher Recent Development
Table 46. GenScript Company Information
Table 47. GenScript Business Overview
Table 48. GenScript Antibody Services Revenue (US$ Million) and Gross Margin (2019-2024)
Table 49. GenScript Antibody Services Product Portfolio
Table 50. GenScript Recent Development
Table 51. Abcam Company Information
Table 52. Abcam Business Overview
Table 53. Abcam Antibody Services Revenue (US$ Million) and Gross Margin (2019-2024)
Table 54. Abcam Antibody Services Product Portfolio
Table 55. Abcam Recent Development
Table 56. MBS Company Information
Table 57. MBS Business Overview
Table 58. MBS Antibody Services Revenue (US$ Million) and Gross Margin (2019-2024)
Table 59. MBS Antibody Services Product Portfolio
Table 60. MBS Recent Development
Table 61. ROCKLAND Company Information
Table 62. ROCKLAND Business Overview
Table 63. ROCKLAND Antibody Services Revenue (US$ Million) and Gross Margin (2019-2024)
Table 64. ROCKLAND Antibody Services Product Portfolio
Table 65. ROCKLAND Recent Development
Table 66. ProSci Company Information
Table 67. ProSci Business Overview
Table 68. ProSci Antibody Services Revenue (US$ Million) and Gross Margin (2019-2024)
Table 69. ProSci Antibody Services Product Portfolio
Table 70. ProSci Recent Development
Table 71. Anaspec Company Information
Table 72. Anaspec Business Overview
Table 73. Anaspec Antibody Services Revenue (US$ Million) and Gross Margin (2019-2024)
Table 74. Anaspec Antibody Services Product Portfolio
Table 75. Anaspec Recent Development
Table 76. Bio-Rad Company Information
Table 77. Bio-Rad Business Overview
Table 78. Bio-Rad Antibody Services Revenue (US$ Million) and Gross Margin (2019-2024)
Table 79. Bio-Rad Antibody Services Product Portfolio
Table 80. Bio-Rad Recent Development
Table 81. Covance Company Information
Table 82. Covance Business Overview
Table 83. Covance Antibody Services Revenue (US$ Million) and Gross Margin (2019-2024)
Table 84. Covance Antibody Services Product Portfolio
Table 85. Covance Recent Development
Table 86. Capra Science Company Information
Table 87. Capra Science Business Overview
Table 88. Capra Science Antibody Services Revenue (US$ Million) and Gross Margin (2019-2024)
Table 89. Capra Science Antibody Services Product Portfolio
Table 90. Capra Science Recent Development
Table 91. Innovagen Company Information
Table 92. Innovagen Business Overview
Table 93. Innovagen Antibody Services Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Innovagen Antibody Services Product Portfolio
Table 95. Innovagen Recent Development
Table 96. APS Company Information
Table 97. APS Business Overview
Table 98. APS Antibody Services Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. APS Antibody Services Product Portfolio
Table 100. APS Recent Development
Table 101. Randox Company Information
Table 102. Randox Business Overview
Table 103. Randox Antibody Services Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Randox Antibody Services Product Portfolio
Table 105. Randox Recent Development
Table 106. GL Biochem Company Information
Table 107. GL Biochem Business Overview
Table 108. GL Biochem Antibody Services Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. GL Biochem Antibody Services Product Portfolio
Table 110. GL Biochem Recent Development
Table 111. Abgent Company Information
Table 112. Abgent Business Overview
Table 113. Abgent Antibody Services Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Abgent Antibody Services Product Portfolio
Table 115. Abgent Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Authors List of This Report
Table 118. Secondary Sources
Table 119. Primary Sources
Table 1. Antibody Services Industry Trends
Table 2. Antibody Services Industry Drivers
Table 3. Antibody Services Industry Opportunities and Challenges
Table 4. Antibody Services Industry Restraints
Table 5. Global Antibody Services Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Antibody Services Revenue Share by Company (2019-2024)
Table 7. Global Antibody Services Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 8. Global Antibody Services Key Company Manufacturing Base & Headquarters
Table 9. Global Antibody Services Company, Product Type & Application
Table 10. Global Antibody Services Company Commercialization Time
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global Antibody Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Major Companies of Monoclonal
Table 15. Major Companies of Polyclonal
Table 16. Major Companies of Others
Table 17. Global Antibody Services Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 18. Global Antibody Services Sales Value by Type (2019-2024) & (US$ Million)
Table 19. Global Antibody Services Sales Value by Type (2025-2030) & (US$ Million)
Table 20. Global Antibody Services Sales Value Share by Type (2019-2024)
Table 21. Global Antibody Services Sales Value Share by Type (2025-2030)
Table 22. Major Companies of BioScience Companies
Table 23. Major Companies of BioScience Research Institutions
Table 24. Major Companies of Hospitals
Table 25. Major Companies of Other
Table 26. Global Antibody Services Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 27. Global Antibody Services Sales Value by Application (2019-2024) & (US$ Million)
Table 28. Global Antibody Services Sales Value by Application (2025-2030) & (US$ Million)
Table 29. Global Antibody Services Sales Value Share by Application (2019-2024)
Table 30. Global Antibody Services Sales Value Share by Application (2025-2030)
Table 31. Global Antibody Services Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 32. Global Antibody Services Sales Value by Region (2019-2024) & (US$ Million)
Table 33. Global Antibody Services Sales Value Share by Region (2019-2024)
Table 34. Global Antibody Services Sales Value by Region (2025-2030) & (US$ Million)
Table 35. Global Antibody Services Sales Value Share by Region (2025-2030)
Table 36. Global Antibody Services Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 37. Global Antibody Services Sales Value by Country (2019-2024) & (US$ Million)
Table 38. Global Antibody Services Sales Value Market Share by Country (2019-2024)
Table 39. Global Antibody Services Sales Value by Country (2025-2030) & (US$ Million)
Table 40. Global Antibody Services Sales Value Market Share by Country (2025-2030)
Table 41. ThermoFisher Company Information
Table 42. ThermoFisher Business Overview
Table 43. ThermoFisher Antibody Services Revenue (US$ Million) and Gross Margin (2019-2024)
Table 44. ThermoFisher Antibody Services Product Portfolio
Table 45. ThermoFisher Recent Development
Table 46. GenScript Company Information
Table 47. GenScript Business Overview
Table 48. GenScript Antibody Services Revenue (US$ Million) and Gross Margin (2019-2024)
Table 49. GenScript Antibody Services Product Portfolio
Table 50. GenScript Recent Development
Table 51. Abcam Company Information
Table 52. Abcam Business Overview
Table 53. Abcam Antibody Services Revenue (US$ Million) and Gross Margin (2019-2024)
Table 54. Abcam Antibody Services Product Portfolio
Table 55. Abcam Recent Development
Table 56. MBS Company Information
Table 57. MBS Business Overview
Table 58. MBS Antibody Services Revenue (US$ Million) and Gross Margin (2019-2024)
Table 59. MBS Antibody Services Product Portfolio
Table 60. MBS Recent Development
Table 61. ROCKLAND Company Information
Table 62. ROCKLAND Business Overview
Table 63. ROCKLAND Antibody Services Revenue (US$ Million) and Gross Margin (2019-2024)
Table 64. ROCKLAND Antibody Services Product Portfolio
Table 65. ROCKLAND Recent Development
Table 66. ProSci Company Information
Table 67. ProSci Business Overview
Table 68. ProSci Antibody Services Revenue (US$ Million) and Gross Margin (2019-2024)
Table 69. ProSci Antibody Services Product Portfolio
Table 70. ProSci Recent Development
Table 71. Anaspec Company Information
Table 72. Anaspec Business Overview
Table 73. Anaspec Antibody Services Revenue (US$ Million) and Gross Margin (2019-2024)
Table 74. Anaspec Antibody Services Product Portfolio
Table 75. Anaspec Recent Development
Table 76. Bio-Rad Company Information
Table 77. Bio-Rad Business Overview
Table 78. Bio-Rad Antibody Services Revenue (US$ Million) and Gross Margin (2019-2024)
Table 79. Bio-Rad Antibody Services Product Portfolio
Table 80. Bio-Rad Recent Development
Table 81. Covance Company Information
Table 82. Covance Business Overview
Table 83. Covance Antibody Services Revenue (US$ Million) and Gross Margin (2019-2024)
Table 84. Covance Antibody Services Product Portfolio
Table 85. Covance Recent Development
Table 86. Capra Science Company Information
Table 87. Capra Science Business Overview
Table 88. Capra Science Antibody Services Revenue (US$ Million) and Gross Margin (2019-2024)
Table 89. Capra Science Antibody Services Product Portfolio
Table 90. Capra Science Recent Development
Table 91. Innovagen Company Information
Table 92. Innovagen Business Overview
Table 93. Innovagen Antibody Services Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Innovagen Antibody Services Product Portfolio
Table 95. Innovagen Recent Development
Table 96. APS Company Information
Table 97. APS Business Overview
Table 98. APS Antibody Services Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. APS Antibody Services Product Portfolio
Table 100. APS Recent Development
Table 101. Randox Company Information
Table 102. Randox Business Overview
Table 103. Randox Antibody Services Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Randox Antibody Services Product Portfolio
Table 105. Randox Recent Development
Table 106. GL Biochem Company Information
Table 107. GL Biochem Business Overview
Table 108. GL Biochem Antibody Services Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. GL Biochem Antibody Services Product Portfolio
Table 110. GL Biochem Recent Development
Table 111. Abgent Company Information
Table 112. Abgent Business Overview
Table 113. Abgent Antibody Services Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Abgent Antibody Services Product Portfolio
Table 115. Abgent Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Authors List of This Report
Table 118. Secondary Sources
Table 119. Primary Sources
LIST OF FIGURES
Figure 1. Antibody Services Product Picture
Figure 2. Global Antibody Services Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Antibody Services Market Size (2019-2030) & (US$ Million)
Figure 4. Global Antibody Services Company Revenue Ranking in 2023 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 7. Monoclonal Picture
Figure 8. Polyclonal Picture
Figure 9. Others Picture
Figure 10. Global Antibody Services Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Antibody Services Sales Value Share 2019 VS 2023 VS 2030
Figure 12. Global Antibody Services Sales Value Share by Type (2019-2030)
Figure 13. BioScience Companies Picture
Figure 14. BioScience Research Institutions Picture
Figure 15. Hospitals Picture
Figure 16. Other Picture
Figure 17. Global Antibody Services Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Antibody Services Sales Value Share 2019 VS 2023 VS 2030
Figure 19. Global Antibody Services Sales Value Share by Application (2019-2030)
Figure 20. Global Antibody Services Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 21. Global Antibody Services Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 22. North America Antibody Services Sales Value (2019-2030) & (US$ Million)
Figure 23. North America Antibody Services Sales Value Share by Country (%), 2023 VS 2030
Figure 24. Europe Antibody Services Sales Value (2019-2030) & (US$ Million)
Figure 25. Europe Antibody Services Sales Value Share by Country (%), 2023 VS 2030
Figure 26. Asia-Pacific Antibody Services Sales Value (2019-2030) & (US$ Million)
Figure 27. Asia-Pacific Antibody Services Sales Value Share by Country (%), 2023 VS 2030
Figure 28. Latin America Antibody Services Sales Value (2019-2030) & (US$ Million)
Figure 29. Latin America Antibody Services Sales Value Share by Country (%), 2023 VS 2030
Figure 30. Middle East & Africa Antibody Services Sales Value (2019-2030) & (US$ Million)
Figure 31. Middle East & Africa Antibody Services Sales Value Share by Country (%), 2023 VS 2030
Figure 32. USA Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 33. USA Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 34. USA Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 35. Canada Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 36. Canada Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 37. Canada Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 38. Germany Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 39. Germany Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 40. Germany Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 41. France Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 42. France Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 43. France Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 44. U.K. Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 45. U.K. Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 46. U.K. Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 47. Italy Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 48. Italy Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 49. Italy Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 50. Netherlands Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 51. Netherlands Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 52. Netherlands Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 53. Nordic Countries Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 54. Nordic Countries Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 55. Nordic Countries Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 56. China Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 57. China Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 58. China Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 59. Japan Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 60. Japan Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 61. Japan Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 62. South Korea Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 63. South Korea Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 64. South Korea Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 65. Southeast Asia Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 66. Southeast Asia Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 67. Southeast Asia Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 68. India Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 69. India Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 70. India Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 71. Australia Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 72. Australia Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 73. Australia Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 74. Mexico Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 75. Mexico Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 76. Mexico Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 77. Brazil Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 78. Brazil Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 79. Brazil Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 80. Turkey Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 81. Turkey Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 82. Turkey Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 83. Saudi Arabia Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 84. Saudi Arabia Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 85. Saudi Arabia Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 86. UAE Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 87. UAE Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 88. UAE Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 89. Years Considered
Figure 90. Research Process
Figure 91. Key Executives Interviewed
Figure 1. Antibody Services Product Picture
Figure 2. Global Antibody Services Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Antibody Services Market Size (2019-2030) & (US$ Million)
Figure 4. Global Antibody Services Company Revenue Ranking in 2023 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 7. Monoclonal Picture
Figure 8. Polyclonal Picture
Figure 9. Others Picture
Figure 10. Global Antibody Services Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Antibody Services Sales Value Share 2019 VS 2023 VS 2030
Figure 12. Global Antibody Services Sales Value Share by Type (2019-2030)
Figure 13. BioScience Companies Picture
Figure 14. BioScience Research Institutions Picture
Figure 15. Hospitals Picture
Figure 16. Other Picture
Figure 17. Global Antibody Services Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Antibody Services Sales Value Share 2019 VS 2023 VS 2030
Figure 19. Global Antibody Services Sales Value Share by Application (2019-2030)
Figure 20. Global Antibody Services Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 21. Global Antibody Services Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 22. North America Antibody Services Sales Value (2019-2030) & (US$ Million)
Figure 23. North America Antibody Services Sales Value Share by Country (%), 2023 VS 2030
Figure 24. Europe Antibody Services Sales Value (2019-2030) & (US$ Million)
Figure 25. Europe Antibody Services Sales Value Share by Country (%), 2023 VS 2030
Figure 26. Asia-Pacific Antibody Services Sales Value (2019-2030) & (US$ Million)
Figure 27. Asia-Pacific Antibody Services Sales Value Share by Country (%), 2023 VS 2030
Figure 28. Latin America Antibody Services Sales Value (2019-2030) & (US$ Million)
Figure 29. Latin America Antibody Services Sales Value Share by Country (%), 2023 VS 2030
Figure 30. Middle East & Africa Antibody Services Sales Value (2019-2030) & (US$ Million)
Figure 31. Middle East & Africa Antibody Services Sales Value Share by Country (%), 2023 VS 2030
Figure 32. USA Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 33. USA Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 34. USA Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 35. Canada Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 36. Canada Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 37. Canada Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 38. Germany Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 39. Germany Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 40. Germany Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 41. France Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 42. France Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 43. France Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 44. U.K. Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 45. U.K. Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 46. U.K. Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 47. Italy Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 48. Italy Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 49. Italy Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 50. Netherlands Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 51. Netherlands Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 52. Netherlands Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 53. Nordic Countries Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 54. Nordic Countries Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 55. Nordic Countries Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 56. China Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 57. China Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 58. China Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 59. Japan Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 60. Japan Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 61. Japan Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 62. South Korea Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 63. South Korea Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 64. South Korea Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 65. Southeast Asia Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 66. Southeast Asia Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 67. Southeast Asia Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 68. India Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 69. India Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 70. India Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 71. Australia Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 72. Australia Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 73. Australia Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 74. Mexico Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 75. Mexico Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 76. Mexico Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 77. Brazil Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 78. Brazil Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 79. Brazil Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 80. Turkey Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 81. Turkey Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 82. Turkey Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 83. Saudi Arabia Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 84. Saudi Arabia Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 85. Saudi Arabia Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 86. UAE Antibody Services Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 87. UAE Antibody Services Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 88. UAE Antibody Services Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 89. Years Considered
Figure 90. Research Process
Figure 91. Key Executives Interviewed
